FELODIPINE EXTENDED-RELEASE TABLETS

FELODIPINE EXTENDED-RELEASE TABLETS was reported 11422 times

FELODIPINE EXTENDED-RELEASE TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 402 0.7204
1 IMMUNISATION 258 0.5945
2 PALMOPLANTAR KERATODERMA 392 0.5407
3 CARDIOPULMONARY EXERCISE TEST ABNORMAL 13 0.4643
4 PELVIC MISALIGNMENT 23 0.4510
5 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY DECREASED 9 0.3000
6 DOPAMINE TRANSPORTER SCINTIGRAPHY ABNORMAL 9 0.2727
7 MENISCOPATHY 12 0.2667
8 FACTOR VII DEFICIENCY 13 0.1940
9 ATRIAL TACHYCARDIA 400 0.1903
10 OROPHARYNGEAL DISCOLOURATION 11 0.1897
11 STEROID DEPENDENCE 160 0.1822
12 CATARRH 163 0.1803
13 PRURITUS GENITAL 397 0.1684
14 PERONEAL NERVE INJURY 13 0.1150
15 CAROTID ARTERY OCCLUSION 401 0.1098
16 NEUROGLYCOPENIA 12 0.1091
17 SACROILIAC JOINT DYSFUNCTION 13 0.0977
18 BURNS SECOND DEGREE 168 0.0957
19 SLEEP TERROR 392 0.0930
20 TENSION HEADACHE 399 0.0927
21 NEUROFIBROMA 13 0.0867
22 VACCINATION SITE SWELLING 11 0.0640
23 HYPOPNOEA 177 0.0509
24 MERYCISM 13 0.0455
25 FACIAL PAIN 406 0.0454
26 SPIDER NAEVUS 8 0.0432
27 ALCOHOL POISONING 112 0.0418
28 SUBARACHNOID HAEMORRHAGE 412 0.0404
29 GREATER TROCHANTERIC PAIN SYNDROME 8 0.0390
30 VASCULITIS 434 0.0372
31 MYOSCLEROSIS 13 0.0352
32 ANOSMIA 401 0.0277
33 BRONCHIECTASIS 184 0.0273
34 PERIPHERAL CIRCULATORY FAILURE 11 0.0268
35 NEUROGENIC SHOCK 14 0.0258
36 JOINT HYPEREXTENSION 10 0.0256
37 PATELLOFEMORAL PAIN SYNDROME 13 0.0253
38 PERICARDITIS 421 0.0250
39 VENTRICULAR TACHYCARDIA 411 0.0249
40 NAIL BED BLEEDING 14 0.0246
41 GLASGOW COMA SCALE ABNORMAL 9 0.0245
42 VESTIBULAR NEURONITIS 13 0.0243
43 IODINE ALLERGY 8 0.0240
44 HELICOBACTER TEST POSITIVE 13 0.0232
45 SCROTAL OEDEMA 16 0.0225
46 GINGIVAL PAIN 176 0.0221
47 PAROSMIA 164 0.0217
48 CARDIAC MURMUR 186 0.0215
49 CERVICOBRACHIAL SYNDROME 13 0.0212
50 RHINITIS 168 0.0208
51 EXTENSOR PLANTAR RESPONSE 19 0.0206
52 STASIS DERMATITIS 14 0.0205
53 MUSCLE TWITCHING 429 0.0186
54 ORTHOSTATIC INTOLERANCE 13 0.0181
55 OVARIAN MASS 12 0.0163
56 TONGUE ERYTHEMA 13 0.0158
57 DIPLOPIA 407 0.0157
58 PAIN OF SKIN 405 0.0150
59 MULTIPLE DRUG THERAPY 11 0.0146
60 COMPUTERISED TOMOGRAM THORAX ABNORMAL 10 0.0146
61 LIP SWELLING 479 0.0144
62 MEAN PLATELET VOLUME DECREASED 12 0.0143
63 VASCULITIC RASH 11 0.0142
64 SKIN OEDEMA 14 0.0140
65 SOLAR LENTIGO 13 0.0137
66 RASH PAPULAR 306 0.0136
67 AORTIC DILATATION 15 0.0135
68 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 8 0.0131
69 TINNITUS 600 0.0130
70 TRANSIENT ISCHAEMIC ATTACK 439 0.0130
71 ABDOMINAL LYMPHADENOPATHY 11 0.0127
72 EYE PRURITUS 411 0.0122
73 NEPHRITIS INTERSTITIAL 15 0.0119
74 KERATOACANTHOMA 8 0.0117
75 NODAL ARRHYTHMIA 10 0.0116
76 TUBULOINTERSTITIAL NEPHRITIS 216 0.0115
77 BLOOD CREATINE INCREASED 51 0.0115
78 ANGIOEDEMA 502 0.0113
79 OSTEOCHONDROSIS 13 0.0112
80 PULMONARY VALVE INCOMPETENCE 16 0.0109
81 NODAL RHYTHM 16 0.0109
82 PO2 DECREASED 12 0.0104
83 IMPAIRED QUALITY OF LIFE 150 0.0104
84 BLINDNESS 409 0.0100
85 NAIL GROWTH ABNORMAL 11 0.0100
86 GINGIVAL HYPERTROPHY 15 0.0099
87 DEMYELINATING POLYNEUROPATHY 10 0.0097
88 MONOCYTE COUNT DECREASED 11 0.0090
89 COGNITIVE DISORDER 417 0.0089
90 KNEE DEFORMITY 13 0.0087
91 LIP DISCOLOURATION 11 0.0087
92 PERIPHERAL EMBOLISM 10 0.0087
93 NEOPLASM SKIN 13 0.0084
94 DISTURBANCE IN ATTENTION 451 0.0084
95 GRANULOMATOSIS WITH POLYANGIITIS 10 0.0083
96 ANGIONEUROTIC OEDEMA 22 0.0082
97 OBSTRUCTIVE SLEEP APNOEA SYNDROME 12 0.0082
98 METABOLIC ALKALOSIS 13 0.0081
99 FREQUENT BOWEL MOVEMENTS 213 0.0079
100 PERIPHERAL ARTERY OCCLUSION 11 0.0078
101 ATRIOVENTRICULAR BLOCK FIRST DEGREE 33 0.0076
102 PUPILLARY REFLEX IMPAIRED 14 0.0076
103 GASTRIC POLYPS 17 0.0075
104 SWOLLEN TONGUE 235 0.0075
105 IMPAIRED WORK ABILITY 155 0.0072
106 PLEURITIC PAIN 20 0.0072
107 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 12 0.0072
108 MONOPARESIS 13 0.0072
109 BRONCHIAL SECRETION RETENTION 9 0.0071
110 EXOPHTHALMOS 15 0.0070
111 BLOOD PHOSPHORUS INCREASED 19 0.0070
112 HYPERTENSIVE HEART DISEASE 13 0.0069
113 HALLUCINATION 509 0.0067
114 VASOPLEGIA SYNDROME 11 0.0067
115 NIGHTMARE 230 0.0066
116 AMNESIA 430 0.0066
117 PERIARTHRITIS 15 0.0066
118 DAYDREAMING 10 0.0065
119 RECTAL HAEMORRHAGE 278 0.0065
120 BLOOD CHOLESTEROL DECREASED 12 0.0064
121 HYPERLACTACIDAEMIA 17 0.0063
122 TESTICULAR SWELLING 8 0.0063
123 EXTREMITY NECROSIS 11 0.0063
124 MIGRAINE 591 0.0062
125 ACTINIC KERATOSIS 16 0.0062
126 CORONARY ARTERY STENOSIS 31 0.0062
127 PALPITATIONS 710 0.0061
128 HYPERREFLEXIA 21 0.0060
129 ACCIDENTAL OVERDOSE 217 0.0059
130 HOSTILITY 15 0.0059
131 CLUMSINESS 16 0.0059
132 CLONUS 16 0.0058
133 NEPHROGENIC ANAEMIA 27 0.0058
134 DISTRIBUTIVE SHOCK 13 0.0057
135 FOOD INTERACTION 10 0.0057
136 BENIGN PROSTATIC HYPERPLASIA 29 0.0056
137 MIGRAINE WITH AURA 15 0.0055
138 SEDATION COMPLICATION 14 0.0055
139 LYMPH NODE PAIN 10 0.0054
140 GLOMERULONEPHRITIS 13 0.0053
141 TACHYCARDIA 471 0.0053
142 INTENTIONAL PRODUCT USE ISSUE 464 0.0053
143 AORTIC VALVE INCOMPETENCE 22 0.0052
144 SYSTEMIC LUPUS ERYTHEMATOSUS 182 0.0051
145 HAEMORRHAGE URINARY TRACT 13 0.0051
146 COLITIS ULCERATIVE 227 0.0051
147 ORTHOSTATIC HYPOTENSION 88 0.0050
148 FOAMING AT MOUTH 10 0.0049
149 HEART RATE INCREASED 486 0.0049
150 NASAL DISORDER 13 0.0049
151 MEDICATION ERROR 270 0.0049
152 COMPLICATIONS OF TRANSPLANTED KIDNEY 11 0.0048
153 HYPERKALAEMIA 170 0.0048
154 CHONDROPATHY 13 0.0048
155 HYPERPARATHYROIDISM SECONDARY 12 0.0048
156 THROMBOCYTOSIS 17 0.0046
157 MUSCULAR WEAKNESS 527 0.0046
158 HYPONATRAEMIA 261 0.0046
159 INTENTIONAL PRODUCT MISUSE 397 0.0045
160 OEDEMA MOUTH 14 0.0043
161 TRICUSPID VALVE INCOMPETENCE 34 0.0043
162 ABNORMAL LOSS OF WEIGHT 29 0.0042
163 SNORING 16 0.0042
164 ARTERIOSCLEROSIS CORONARY ARTERY 28 0.0042
165 GLOSSITIS 15 0.0042
166 ECZEMA 220 0.0042
167 THERAPEUTIC AGENT TOXICITY 14 0.0042
168 RENAL FAILURE ACUTE 177 0.0042
169 HYPERTONIC BLADDER 12 0.0042
170 DEHYDRATION 547 0.0041
171 STUPOR 13 0.0040
172 SKIN EROSION 13 0.0040
173 CAROTID ARTERY STENOSIS 14 0.0040
174 HYPERHIDROSIS 515 0.0040
175 SINUS BRADYCARDIA 38 0.0039
176 ELECTRIC SHOCK SENSATION 11 0.0039
177 NEUTROPENIC SEPSIS 28 0.0039
178 SKIN HYPERTROPHY 11 0.0039
179 RENAL FAILURE CHRONIC 30 0.0039
180 FORCED EXPIRATORY VOLUME DECREASED 11 0.0039
181 HYPERPARATHYROIDISM 8 0.0039
182 MELANOCYTIC NAEVUS 17 0.0039
183 SPINAL OSTEOARTHRITIS 34 0.0039
184 ABDOMINAL DISCOMFORT 649 0.0039
185 VISUAL IMPAIRMENT 476 0.0038
186 RALES 22 0.0038
187 POLYURIA 31 0.0038
188 INTERNATIONAL NORMALISED RATIO INCREASED 107 0.0037
189 HAEMATOCHEZIA 207 0.0037
190 INTERVERTEBRAL DISC DISORDER 16 0.0037
191 BRADYKINESIA 22 0.0037
192 STARING 9 0.0037
193 PANNICULITIS 9 0.0037
194 ANGINA UNSTABLE 24 0.0037
195 JAUNDICE CHOLESTATIC 13 0.0037
196 BLOOD ALBUMIN DECREASED 29 0.0037
197 BLOOD UREA INCREASED 61 0.0036
198 DYSGRAPHIA 24 0.0036
199 VERTIGO 222 0.0036
200 BLOOD PRESSURE SYSTOLIC ABNORMAL 9 0.0036
201 ATRIOVENTRICULAR BLOCK SECOND DEGREE 11 0.0036
202 DECREASED ACTIVITY 39 0.0036
203 URINE OUTPUT DECREASED 31 0.0035
204 DUODENAL ULCER 25 0.0035
205 PARKINSON'S DISEASE 9 0.0035
206 PERIPHERAL SWELLING 540 0.0035
207 RESPIRATORY RATE DECREASED 11 0.0035
208 INCONTINENCE 37 0.0035
209 BLOOD PRESSURE INADEQUATELY CONTROLLED 21 0.0035
210 COVID-19 612 0.0035
211 APLASIA PURE RED CELL 12 0.0035
212 PHARYNGEAL DISORDER 10 0.0035
213 MEMORY IMPAIRMENT 476 0.0035
214 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 166 0.0035
215 BLOOD PARATHYROID HORMONE INCREASED 10 0.0034
216 HYPERSENSITIVITY VASCULITIS 9 0.0034
217 PERIPHERAL VENOUS DISEASE 14 0.0034
218 HIATUS HERNIA 44 0.0034
219 BRADYCARDIA 180 0.0034
220 UPPER GASTROINTESTINAL HAEMORRHAGE 57 0.0034
221 SEROTONIN SYNDROME 65 0.0034
222 CHEST PAIN 625 0.0034
223 MELAENA 74 0.0034
224 URINARY HESITATION 8 0.0033
225 DRY SKIN 445 0.0033
226 DEEP VEIN THROMBOSIS 216 0.0033
227 EXTRASYSTOLES 23 0.0033
228 BRONCHITIS CHRONIC 8 0.0033
229 WOUND HAEMORRHAGE 12 0.0032
230 MYOPATHY 28 0.0032
231 DIVERTICULUM 23 0.0032
232 INTERNATIONAL NORMALISED RATIO DECREASED 13 0.0032
233 LEFT VENTRICULAR FAILURE 11 0.0032
234 MYOCARDIAL INFARCTION 552 0.0032
235 NEUTROPHIL COUNT INCREASED 32 0.0031
236 MYOSITIS 28 0.0031
237 OESOPHAGITIS 34 0.0031
238 CORONARY ARTERY DISEASE 94 0.0031
239 MYOCARDIAL ISCHAEMIA 35 0.0031
240 OLIGURIA 19 0.0031
241 RENAL TUBULAR NECROSIS 30 0.0031
242 HYPOKALAEMIA 141 0.0031
243 NOCTURIA 37 0.0030
244 CONFUSIONAL STATE 492 0.0030
245 TEARFULNESS 13 0.0030
246 LIVER FUNCTION TEST ABNORMAL 87 0.0030
247 ADVERSE DRUG REACTION 268 0.0030
248 NEPHROGENIC SYSTEMIC FIBROSIS 9 0.0030
249 PARKINSONISM 29 0.0030
250 PERIPHERAL ISCHAEMIA 12 0.0029
251 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 30 0.0029
252 RED CELL DISTRIBUTION WIDTH INCREASED 12 0.0029
253 HYPOMAGNESAEMIA 40 0.0029
254 SINUS HEADACHE 17 0.0029
255 BLOOD PRESSURE SYSTOLIC DECREASED 13 0.0029
256 ERYTHEMA NODOSUM 10 0.0028
257 DYSGEUSIA 210 0.0028
258 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
259 ARTHRITIS 220 0.0028
260 ANAL FISSURE 15 0.0028
261 DUODENAL ULCER HAEMORRHAGE 8 0.0028
262 FACE OEDEMA 47 0.0028
263 GINGIVITIS 15 0.0028
264 MENISCUS INJURY 17 0.0028
265 MITRAL VALVE INCOMPETENCE 31 0.0027
266 RED BLOOD CELL SEDIMENTATION RATE INCREASED 30 0.0027
267 DIABETES MELLITUS INADEQUATE CONTROL 48 0.0027
268 ALOPECIA 525 0.0027
269 PULMONARY EMBOLISM 254 0.0027
270 PEMPHIGOID 20 0.0026
271 PERONEAL NERVE PALSY 15 0.0026
272 BURSITIS 32 0.0026
273 BACK PAIN 610 0.0026
274 GAMMA-GLUTAMYLTRANSFERASE INCREASED 58 0.0026
275 DIFFICULTY IN WALKING 9 0.0026
276 GRIP STRENGTH DECREASED 23 0.0026
277 BOWEL MOVEMENT IRREGULARITY 20 0.0026
278 JOINT EFFUSION 18 0.0026
279 DUODENITIS 8 0.0026
280 HAEMATEMESIS 66 0.0026
281 FAECES DISCOLOURED 56 0.0026
282 DIZZINESS POSTURAL 25 0.0026
283 EMBOLIC STROKE 9 0.0026
284 THROMBOTIC THROMBOCYTOPENIC PURPURA 9 0.0026
285 BLOOD GLUCOSE INCREASED 478 0.0025
286 ACUTE CORONARY SYNDROME 21 0.0025
287 CHAPPED LIPS 11 0.0025
288 SALIVARY HYPERSECRETION 25 0.0025
289 FAECAL INCONTINENCE 12 0.0025
290 METABOLIC ACIDOSIS 79 0.0025
291 DEAFNESS NEUROSENSORY 8 0.0024
292 CONCOMITANT DISEASE AGGRAVATED 15 0.0024
293 HYPERCALCAEMIA 30 0.0024
294 GASTRIC ULCER 46 0.0024
295 JAUNDICE 65 0.0024
296 ERECTILE DYSFUNCTION 62 0.0024
297 PEPTIC ULCER 8 0.0024
298 HYPOTONIA 24 0.0024
299 EAR DISORDER 11 0.0024
300 HIGH DENSITY LIPOPROTEIN DECREASED 8 0.0024
301 NEPHRITIS 8 0.0024
302 ISCHAEMIA 11 0.0024
303 HYPOVOLAEMIA 14 0.0024
304 FEELING OF BODY TEMPERATURE CHANGE 14 0.0024
305 BLOOD CREATININE INCREASED 155 0.0024
306 MULTI-ORGAN FAILURE 41 0.0024
307 INTESTINAL ISCHAEMIA 13 0.0024
308 GLOMERULAR FILTRATION RATE DECREASED 29 0.0024
309 YELLOW SKIN 11 0.0023
310 ABDOMINAL PAIN UPPER 482 0.0023
311 SKIN TIGHTNESS 11 0.0023
312 PERIPHERAL VASCULAR DISORDER 12 0.0023
313 INTERNATIONAL NORMALISED RATIO ABNORMAL 8 0.0023
314 ANURIA 20 0.0023
315 HAEMATOCRIT DECREASED 46 0.0023
316 MOUTH HAEMORRHAGE 17 0.0023
317 PYREXIA 801 0.0023
318 CARDIOPULMONARY FAILURE 9 0.0023
319 BLOOD PRESSURE DIASTOLIC DECREASED 17 0.0023
320 END STAGE RENAL DISEASE 42 0.0023
321 AORTIC STENOSIS 8 0.0023
322 PULMONARY FUNCTION TEST DECREASED 10 0.0023
323 CANDIDIASIS 9 0.0022
324 ACUTE MYOCARDIAL INFARCTION 66 0.0022
325 ANGINA PECTORIS 64 0.0022
326 LETHARGY 128 0.0022
327 NODULE 29 0.0022
328 URINE ODOUR ABNORMAL 13 0.0022
329 ANXIETY 627 0.0022
330 ATELECTASIS 21 0.0022
331 HAIR GROWTH ABNORMAL 15 0.0022
332 FEELING ABNORMAL 519 0.0022
333 INSOMNIA 571 0.0021
334 SYNCOPE 214 0.0021
335 URINARY RETENTION 71 0.0021
336 SKIN ABRASION 10 0.0021
337 CARDIOMEGALY 26 0.0021
338 DRUG INTERACTION 335 0.0021
339 ATAXIA 25 0.0021
340 URINARY INCONTINENCE 62 0.0021
341 POLYARTHRITIS 11 0.0021
342 RASH VESICULAR 10 0.0021
343 RETINAL DETACHMENT 19 0.0021
344 C-REACTIVE PROTEIN INCREASED 75 0.0021
345 CHROMATURIA 46 0.0020
346 LYMPHOCYTE COUNT DECREASED 36 0.0020
347 DIZZINESS 1012 0.0020
348 RESPIRATORY RATE INCREASED 18 0.0020
349 POLYDIPSIA 8 0.0020
350 IDIOPATHIC PULMONARY FIBROSIS 8 0.0020
351 HYPERNATRAEMIA 10 0.0020
352 GOUT 36 0.0020
353 HAEMATURIA 68 0.0020
354 OBSTRUCTIVE AIRWAYS DISORDER 22 0.0020
355 PRESYNCOPE 48 0.0020
356 TROPONIN INCREASED 15 0.0020
357 OEDEMA PERIPHERAL 240 0.0020
358 HYPERCHOLESTEROLAEMIA 19 0.0020
359 BODY TEMPERATURE INCREASED 40 0.0020
360 LIPASE INCREASED 15 0.0020
361 HYPOCALCAEMIA 37 0.0020
362 BLOOD PRESSURE DIASTOLIC INCREASED 9 0.0019
363 HICCUPS 16 0.0019
364 PALLOR 53 0.0019
365 ANAPHYLACTOID REACTION 8 0.0019
366 BLEPHAROSPASM 12 0.0019
367 EYE MOVEMENT DISORDER 13 0.0019
368 BLOOD ALKALINE PHOSPHATASE INCREASED 47 0.0019
369 PULSE ABSENT 9 0.0019
370 PHARYNGEAL OEDEMA 29 0.0019
371 CEREBROVASCULAR ACCIDENT 318 0.0019
372 HYPOTHERMIA 19 0.0019
373 ROTATOR CUFF SYNDROME 24 0.0019
374 MOTOR DYSFUNCTION 19 0.0019
375 OEDEMA 101 0.0019
376 HYPOGLYCAEMIA 90 0.0019
377 FLUID OVERLOAD 27 0.0019
378 AORTIC ANEURYSM 14 0.0018
379 PROTHROMBIN TIME PROLONGED 11 0.0018
380 GASTRITIS 48 0.0018
381 GROIN PAIN 16 0.0018
382 UNRESPONSIVE TO STIMULI 47 0.0018
383 CIRCULATORY COLLAPSE 31 0.0018
384 DERMATITIS BULLOUS 13 0.0018
385 DYSPNOEA 1009 0.0018
386 UTERINE LEIOMYOMA 13 0.0018
387 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 9 0.0018
388 RENAL CYST 14 0.0018
389 DYSPNOEA EXERTIONAL 66 0.0018
390 HYPERTONIA 10 0.0017
391 OSTEOARTHRITIS 74 0.0017
392 ONYCHOCLASIS 12 0.0017
393 PRURITUS 666 0.0017
394 LIGAMENT SPRAIN 17 0.0017
395 ACUTE KIDNEY INJURY 261 0.0017
396 JOINT DISLOCATION 18 0.0017
397 BLOOD CREATINE PHOSPHOKINASE INCREASED 49 0.0017
398 BLOOD SODIUM DECREASED 32 0.0017
399 ARTHRALGIA 701 0.0017
400 MYOCLONUS 20 0.0017
401 DYSARTHRIA 63 0.0017
402 HAEMODIALYSIS 14 0.0017
403 BASAL CELL CARCINOMA 26 0.0017
404 RENAL IMPAIRMENT 140 0.0017
405 HAEMORRHAGIC STROKE 13 0.0017
406 APHAGIA 8 0.0017
407 BRAIN FOG 26 0.0017
408 TORSADE DE POINTES 13 0.0017
409 EAR DISCOMFORT 17 0.0017
410 RESTLESS LEGS SYNDROME 30 0.0016
411 JOINT SWELLING 199 0.0016
412 ATRIOVENTRICULAR BLOCK COMPLETE 11 0.0016
413 CARDIAC FAILURE CONGESTIVE 132 0.0016
414 PROTEINURIA 31 0.0016
415 LIVER INJURY 40 0.0016
416 HEPARIN-INDUCED THROMBOCYTOPENIA 8 0.0016
417 DIABETIC NEUROPATHY 8 0.0016
418 ANGIOPATHY 9 0.0016
419 MALAISE 703 0.0016
420 BLOOD CALCIUM DECREASED 18 0.0016
421 PROSTATIC SPECIFIC ANTIGEN INCREASED 22 0.0016
422 PRODUCT PRESCRIBING ERROR 38 0.0016
423 BLOOD PRESSURE FLUCTUATION 38 0.0016
424 PHOTOPSIA 10 0.0016
425 VOMITING 742 0.0016
426 CORONARY ARTERIAL STENT INSERTION 8 0.0016
427 BLOOD LACTATE DEHYDROGENASE INCREASED 25 0.0016
428 PATHOLOGICAL FRACTURE 8 0.0016
429 DRY THROAT 16 0.0016
430 INCORRECT PRODUCT ADMINISTRATION DURATION 34 0.0016
431 HAEMOGLOBIN DECREASED 161 0.0016
432 PAIN IN EXTREMITY 460 0.0016
433 HYPOTENSION 312 0.0016
434 CEREBRAL ISCHAEMIA 8 0.0016
435 ANOREXIA 20 0.0016
436 ELECTROLYTE IMBALANCE 18 0.0015
437 EJECTION FRACTION DECREASED 24 0.0015
438 ABDOMINAL HERNIA 7 0.0015
439 ELECTROCARDIOGRAM ABNORMAL 12 0.0015
440 HEPATOMEGALY 15 0.0015
441 BLOOD LACTIC ACID INCREASED 8 0.0015
442 LOWER RESPIRATORY TRACT INFECTION 69 0.0015
443 BLOOD IRON DECREASED 18 0.0015
444 NERVE COMPRESSION 14 0.0015
445 ATRIAL FIBRILLATION 147 0.0015
446 GASTROINTESTINAL HAEMORRHAGE 126 0.0015
447 HYPERLIPIDAEMIA 18 0.0015
448 EYE INFECTION 17 0.0015
449 MUSCLE RIGIDITY 18 0.0015
450 ATRIAL FLUTTER 12 0.0015
451 SKIN DISCOLOURATION 69 0.0015
452 SENSORY LOSS 12 0.0015
453 ARTERIOSCLEROSIS 14 0.0015
454 STRESS FRACTURE 8 0.0015
455 HYPERGLYCAEMIA 54 0.0015
456 BLOOD POTASSIUM INCREASED 24 0.0015
457 DYSKINESIA 60 0.0015
458 SOMNOLENCE 297 0.0015
459 HALLUCINATION, VISUAL 31 0.0015
460 PARALYSIS 21 0.0015
461 RHABDOMYOLYSIS 61 0.0015
462 DIABETIC KETOACIDOSIS 35 0.0015
463 FATIGUE 1127 0.0014
464 LARGE INTESTINE POLYP 10 0.0014
465 AGITATION 106 0.0014
466 NEURALGIA 35 0.0014
467 ACIDOSIS 11 0.0014
468 NERVE INJURY 16 0.0014
469 PETECHIAE 15 0.0014
470 NASAL DRYNESS 9 0.0014
471 BLOOD PRESSURE SYSTOLIC INCREASED 28 0.0014
472 HEADACHE 899 0.0014
473 PLEURAL EFFUSION 87 0.0014
474 HAEMATOMA 37 0.0014
475 PAIN 872 0.0014
476 PULMONARY MASS 21 0.0014
477 SINUS TACHYCARDIA 20 0.0014
478 PULMONARY FIBROSIS 27 0.0014
479 BRONCHOSPASM 20 0.0014
480 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 24 0.0014
481 VISUAL DISTURBANCE 8 0.0014
482 HEPATIC ENCEPHALOPATHY 13 0.0014
483 LACTIC ACIDOSIS 45 0.0014
484 DIARRHOEA 895 0.0014
485 BLOOD URIC ACID INCREASED 8 0.0014
486 BLOOD PRESSURE DECREASED 92 0.0014
487 RASH PRURITIC 75 0.0014
488 DELIRIUM 48 0.0014
489 RENAL INJURY 41 0.0014
490 METABOLIC DISORDER 8 0.0014
491 POLYP 9 0.0014
492 SOMNAMBULISM 9 0.0014
493 SENSORY DISTURBANCE 22 0.0014
494 PHARYNGITIS 17 0.0014
495 MENTAL STATUS CHANGES 38 0.0014
496 DISORIENTATION 54 0.0014
497 DEPRESSION 309 0.0014
498 PURPURA 12 0.0014
499 RENAL FAILURE 180 0.0014
500 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
501 COLITIS 51 0.0013
502 CARDIOTOXICITY 12 0.0013
503 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
504 ORAL PAIN 30 0.0013
505 WEIGHT DECREASED 374 0.0013
506 HAIR DISORDER 11 0.0013
507 HAEMORRHOIDS 26 0.0013
508 ULCER 21 0.0013
509 AKATHISIA 18 0.0013
510 HYPERTENSION 279 0.0013
511 EPISTAXIS 98 0.0013
512 MULTIPLE ORGAN DYSFUNCTION SYNDROME 37 0.0013
513 GASTROENTERITIS 19 0.0013
514 RASH 566 0.0013
515 RASH ERYTHEMATOUS 62 0.0013
516 PULMONARY HYPERTENSION 27 0.0013
517 AUTOIMMUNE HEPATITIS 9 0.0013
518 AGRANULOCYTOSIS 24 0.0013
519 CELLULITIS 65 0.0013
520 ILEUS 16 0.0013
521 HYPOALBUMINAEMIA 10 0.0013
522 HAIR COLOUR CHANGES 16 0.0013
523 LEUKOCYTOSIS 23 0.0013
524 SKIN SWELLING 11 0.0013
525 BLOOD POTASSIUM DECREASED 38 0.0013
526 CHRONIC KIDNEY DISEASE 96 0.0013
527 SWELLING FACE 82 0.0013
528 BLOOD BILIRUBIN INCREASED 34 0.0013
529 APHASIA 38 0.0013
530 JOINT STIFFNESS 33 0.0013
531 BLOOD CALCIUM INCREASED 11 0.0013
532 OSTEOPENIA 19 0.0013
533 VENTRICULAR EXTRASYSTOLES 13 0.0013
534 POLLAKIURIA 52 0.0012
535 LUNG INFILTRATION 11 0.0012
536 ACUTE HEPATIC FAILURE 17 0.0012
537 ASPARTATE AMINOTRANSFERASE INCREASED 66 0.0012
538 MYALGIA 210 0.0012
539 MOUTH ULCERATION 26 0.0012
540 BACTERIAL INFECTION 23 0.0012
541 ISCHAEMIC STROKE 22 0.0012
542 INTENTIONAL OVERDOSE 79 0.0012
543 CEREBRAL INFARCTION 30 0.0012
544 PLATELET COUNT INCREASED 16 0.0012
545 HEART RATE DECREASED 43 0.0012
546 DEAFNESS 32 0.0012
547 ELECTROCARDIOGRAM QT PROLONGED 44 0.0012
548 DRY MOUTH 99 0.0012
549 SENSITIVE SKIN 9 0.0012
550 OSTEOMYELITIS 22 0.0012
551 ABASIA 30 0.0012
552 WALKING AID USER 8 0.0012
553 ANAEMIA 231 0.0012
554 PERICARDIAL EFFUSION 28 0.0012
555 NIGHT SWEATS 39 0.0012
556 EYELID OEDEMA 14 0.0012
557 COAGULOPATHY 20 0.0012
558 WHEEZING 71 0.0012
559 QUALITY OF LIFE DECREASED 16 0.0012
560 ECONOMIC PROBLEM 18 0.0012
561 CARDIAC ARREST 98 0.0012
562 HAEMODYNAMIC INSTABILITY 9 0.0012
563 DEMENTIA 33 0.0012
564 BALANCE DISORDER 102 0.0012
565 AGGRESSION 59 0.0012
566 TOOTH ABSCESS 12 0.0012
567 NEPHROPATHY 11 0.0012
568 INITIAL INSOMNIA 12 0.0012
569 ATRIOVENTRICULAR BLOCK 9 0.0012
570 PULMONARY OEDEMA 52 0.0012
571 RESPIRATION ABNORMAL 8 0.0012
572 PSYCHOLOGICAL TRAUMA 10 0.0012
573 LYMPHOEDEMA 8 0.0012
574 OXYGEN SATURATION DECREASED 65 0.0012
575 MOBILITY DECREASED 83 0.0012
576 CONDITION AGGRAVATED 351 0.0012
577 RED BLOOD CELL COUNT DECREASED 33 0.0012
578 SLEEP APNOEA SYNDROME 22 0.0012
579 DEFAECATION URGENCY 8 0.0011
580 DYSURIA 42 0.0011
581 BLOOD PRESSURE INCREASED 174 0.0011
582 DYSPHAGIA 108 0.0011
583 TUMOUR LYSIS SYNDROME 10 0.0011
584 NAUSEA 896 0.0011
585 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
586 EAR PAIN 22 0.0011
587 TYPE 2 DIABETES MELLITUS 38 0.0011
588 CYST 14 0.0011
589 PHARYNGEAL SWELLING 11 0.0011
590 ALANINE AMINOTRANSFERASE INCREASED 69 0.0011
591 HAIR TEXTURE ABNORMAL 15 0.0011
592 RESTLESSNESS 41 0.0011
593 OSTEOPOROSIS 46 0.0011
594 SUBDURAL HAEMATOMA 16 0.0011
595 FEELING COLD 31 0.0011
596 PANCREATITIS ACUTE 25 0.0011
597 ANAL INCONTINENCE 10 0.0011
598 PRURITUS GENERALISED 24 0.0011
599 MUSCULOSKELETAL STIFFNESS 97 0.0011
600 SKIN LACERATION 12 0.0011
601 TENDONITIS 17 0.0011
602 CARDIAC FAILURE 88 0.0011
603 ACUTE RESPIRATORY FAILURE 21 0.0011
604 EMPHYSEMA 11 0.0011
605 FLUID RETENTION 55 0.0011
606 HYPOXIA 38 0.0011
607 WHITE BLOOD CELL COUNT INCREASED 41 0.0011
608 HYDRONEPHROSIS 8 0.0011
609 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 192 0.0011
610 THIRST 19 0.0011
611 RASH MACULAR 37 0.0011
612 DRUG-INDUCED LIVER INJURY 33 0.0011
613 EXTRAPYRAMIDAL DISORDER 26 0.0010
614 POST PROCEDURAL COMPLICATION 20 0.0010
615 SECRETION DISCHARGE 13 0.0010
616 HERNIA 20 0.0010
617 LOCAL SWELLING 18 0.0010
618 ANAPHYLACTIC REACTION 57 0.0010
619 POST PROCEDURAL HAEMORRHAGE 12 0.0010
620 SPEECH DISORDER 54 0.0010
621 PAIN IN JAW 29 0.0010
622 PARAESTHESIA 161 0.0010
623 CORONARY ARTERY OCCLUSION 14 0.0010
624 ASPIRATION 11 0.0010
625 APHONIA 14 0.0010
626 HIP FRACTURE 32 0.0010
627 DYSSTASIA 29 0.0010
628 VENTRICULAR FIBRILLATION 11 0.0010
629 ABDOMINAL PAIN 230 0.0010
630 INFLAMMATION 51 0.0010
631 DIALYSIS 14 0.0010
632 DEPRESSED LEVEL OF CONSCIOUSNESS 39 0.0010
633 PRODUCTIVE COUGH 47 0.0010
634 NO THERAPEUTIC RESPONSE 12 0.0010
635 NEPHROPATHY TOXIC 11 0.0010
636 FALL 326 0.0010
637 SPINAL COMPRESSION FRACTURE 8 0.0010
638 FEAR 26 0.0010
639 PANCYTOPENIA 54 0.0010
640 DEPRESSED MOOD 51 0.0010
641 EMBOLISM 8 0.0010
642 DIARRHOEA HAEMORRHAGIC 9 0.0010
643 ASTHENIA 362 0.0010
644 AGEUSIA 24 0.0010
645 HEPATIC FAILURE 29 0.0010
646 INTERVERTEBRAL DISC PROTRUSION 21 0.0010
647 SQUAMOUS CELL CARCINOMA 9 0.0010
648 DRUG TOXICITY 13 0.0010
649 MUSCULOSKELETAL PAIN 50 0.0010
650 TREMOR 158 0.0010
651 OROPHARYNGEAL PAIN 88 0.0009
652 ARRHYTHMIA 45 0.0009
653 PRODUCT USE IN UNAPPROVED INDICATION 235 0.0009
654 RESPIRATORY FAILURE 69 0.0009
655 SUDDEN DEATH 10 0.0009
656 MUSCLE SPASMS 173 0.0009
657 HYPERSOMNIA 27 0.0009
658 ABNORMAL DREAMS 26 0.0009
659 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
660 LUNG DISORDER 46 0.0009
661 COORDINATION ABNORMAL 13 0.0009
662 NECK PAIN 52 0.0009
663 PARANOIA 16 0.0009
664 CONSTIPATION 202 0.0009
665 MUSCLE STRAIN 8 0.0009
666 CEREBRAL HAEMORRHAGE 33 0.0009
667 BLINDNESS UNILATERAL 13 0.0009
668 BLOOD GLUCOSE ABNORMAL 17 0.0009
669 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 48 0.0009
670 GAIT DISTURBANCE 176 0.0009
671 POLYNEUROPATHY 11 0.0009
672 KIDNEY INFECTION 18 0.0009
673 CHOLELITHIASIS 30 0.0009
674 ANHEDONIA 24 0.0009
675 RESPIRATORY ARREST 25 0.0009
676 BLADDER DISORDER 9 0.0009
677 DRUG LEVEL INCREASED 15 0.0009
678 PARAESTHESIA ORAL 13 0.0009
679 HYPOPHAGIA 23 0.0009
680 HYPERTENSIVE CRISIS 10 0.0009
681 CYTOPENIA 11 0.0009
682 FEELING HOT 55 0.0009
683 MENTAL DISORDER 39 0.0009
684 BLOOD URINE PRESENT 17 0.0009
685 MALNUTRITION 10 0.0009
686 RASH GENERALISED 23 0.0009
687 EYE PAIN 50 0.0009
688 GASTROOESOPHAGEAL REFLUX DISEASE 71 0.0009
689 LOSS OF CONSCIOUSNESS 113 0.0009
690 DRY EYE 44 0.0009
691 COUGH 247 0.0009
692 OPTIC NEURITIS 8 0.0009
693 BLOOD CHOLESTEROL INCREASED 41 0.0009
694 MUSCULOSKELETAL DISCOMFORT 15 0.0009
695 CLOSTRIDIUM DIFFICILE INFECTION 19 0.0009
696 INCREASED TENDENCY TO BRUISE 8 0.0009
697 IRON DEFICIENCY ANAEMIA 8 0.0009
698 MADAROSIS 10 0.0009
699 CHEST DISCOMFORT 88 0.0009
700 DERMATITIS 18 0.0009
701 WOUND 24 0.0009
702 MYDRIASIS 11 0.0009
703 CARPAL TUNNEL SYNDROME 12 0.0009
704 BLOOD PRESSURE ABNORMAL 17 0.0009
705 SPINAL PAIN 10 0.0009
706 CONTUSION 82 0.0009
707 COLD SWEAT 15 0.0009
708 PNEUMONIA 275 0.0008
709 RENAL PAIN 9 0.0008
710 STAPHYLOCOCCAL INFECTION 28 0.0008
711 HIP ARTHROPLASTY 13 0.0008
712 GLOSSODYNIA 19 0.0008
713 LYMPHADENOPATHY 30 0.0008
714 SPUTUM DISCOLOURED 8 0.0008
715 HEART RATE IRREGULAR 19 0.0008
716 LUNG INFECTION 13 0.0008
717 CARDIOGENIC SHOCK 12 0.0008
718 PULMONARY CONGESTION 11 0.0008
719 RESPIRATORY DISTRESS 23 0.0008
720 URINARY TRACT INFECTION 142 0.0008
721 ADRENAL INSUFFICIENCY 10 0.0008
722 VISION BLURRED 113 0.0008
723 DECREASED APPETITE 191 0.0008
724 THROMBOTIC MICROANGIOPATHY 8 0.0008
725 PERITONITIS 17 0.0008
726 ABSCESS 13 0.0008
727 THERAPY CHANGE 8 0.0008
728 VISUAL ACUITY REDUCED 27 0.0008
729 OFF LABEL USE 710 0.0008
730 TRANSAMINASES INCREASED 18 0.0008
731 COLON CANCER 12 0.0008
732 MIDDLE INSOMNIA 15 0.0008
733 SEPSIS 89 0.0008
734 ORAL DISCOMFORT 11 0.0008
735 TASTE DISORDER 16 0.0008
736 DIABETES MELLITUS 60 0.0008
737 BONE PAIN 46 0.0008
738 SKIN REACTION 11 0.0008
739 THROAT IRRITATION 35 0.0008
740 GLAUCOMA 15 0.0008
741 HELICOBACTER INFECTION 8 0.0008
742 LYMPHOMA 12 0.0008
743 FLUSHING 78 0.0008
744 COVID-19 PNEUMONIA 9 0.0008
745 DIVERTICULITIS 21 0.0008
746 MACULAR DEGENERATION 9 0.0008
747 OBESITY 12 0.0008
748 RENAL DISORDER 35 0.0008
749 RETCHING 16 0.0007
750 EYE HAEMORRHAGE 10 0.0007
751 INTENTIONAL SELF-INJURY 15 0.0007
752 FEMUR FRACTURE 23 0.0007
753 HYPOAESTHESIA 111 0.0007
754 METASTASES TO LIVER 13 0.0007
755 PANCREATITIS 39 0.0007
756 SLEEP DISORDER 52 0.0007
757 UPPER RESPIRATORY TRACT INFECTION 34 0.0007
758 HAEMORRHAGE INTRACRANIAL 11 0.0007
759 TENDON RUPTURE 9 0.0007
760 RHINORRHOEA 47 0.0007
761 CHILLS 85 0.0007
762 TOXIC EPIDERMAL NECROLYSIS 11 0.0007
763 STEVENS-JOHNSON SYNDROME 16 0.0007
764 RASH MACULO-PAPULAR 16 0.0007
765 SEIZURE 83 0.0007
766 BLISTER 40 0.0007
767 LIMB DISCOMFORT 22 0.0007
768 ABDOMINAL DISTENSION 74 0.0007
769 HEMIPARESIS 12 0.0007
770 MENTAL IMPAIRMENT 17 0.0007
771 DYSPEPSIA 69 0.0007
772 SCAR 12 0.0007
773 GENERAL PHYSICAL HEALTH DETERIORATION 81 0.0007
774 PNEUMONITIS 19 0.0007
775 SCIATICA 11 0.0007
776 NERVOUSNESS 36 0.0007
777 THROMBOCYTOPENIA 77 0.0007
778 SEDATION 18 0.0007
779 OSTEONECROSIS OF JAW 17 0.0007
780 DRUG ABUSE 57 0.0007
781 SOPOR 9 0.0007
782 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
783 CARDIOMYOPATHY 10 0.0007
784 TOOTH DISORDER 15 0.0007
785 HYPERSENSITIVITY 125 0.0007
786 EYE SWELLING 25 0.0007
787 CHOLECYSTITIS 8 0.0007
788 INJURY 47 0.0007
789 PRODUCT TASTE ABNORMAL 9 0.0007
790 IMPAIRED GASTRIC EMPTYING 9 0.0007
791 GINGIVAL BLEEDING 9 0.0007
792 SKIN ULCER 17 0.0007
793 ACTIVITIES OF DAILY LIVING IMPAIRED 13 0.0007
794 JOINT INJURY 14 0.0007
795 DRUG DISPENSING ERROR 10 0.0007
796 RESPIRATORY DEPRESSION 8 0.0007
797 COMA 31 0.0007
798 POOR QUALITY SLEEP 14 0.0006
799 BRONCHITIS 48 0.0006
800 HAEMOPTYSIS 18 0.0006
801 HEPATIC FUNCTION ABNORMAL 24 0.0006
802 ACUTE MYELOID LEUKAEMIA 10 0.0006
803 EYE DISORDER 21 0.0006
804 TARDIVE DYSKINESIA 18 0.0006
805 DERMATITIS ALLERGIC 8 0.0006
806 TOXICITY TO VARIOUS AGENTS 107 0.0006
807 RIB FRACTURE 13 0.0006
808 HEAD INJURY 20 0.0006
809 VIRAL INFECTION 21 0.0006
810 NASAL CONGESTION 37 0.0006
811 LIMB INJURY 17 0.0006
812 CHOLESTASIS 12 0.0006
813 SNEEZING 14 0.0006
814 CARDIO-RESPIRATORY ARREST 26 0.0006
815 EPILEPSY 19 0.0006
816 PHARMACEUTICAL PRODUCT COMPLAINT 16 0.0006
817 HEPATIC ENZYME INCREASED 42 0.0006
818 ORAL CANDIDIASIS 8 0.0006
819 CATARACT 36 0.0006
820 BONE DISORDER 11 0.0006
821 PANIC ATTACK 22 0.0006
822 CYTOKINE RELEASE SYNDROME 12 0.0006
823 HOT FLUSH 45 0.0006
824 CYSTITIS 19 0.0006
825 JOINT RANGE OF MOTION DECREASED 8 0.0006
826 CONVULSION 34 0.0006
827 STOMATITIS 36 0.0006
828 HEPATIC STEATOSIS 11 0.0006
829 OCULAR HYPERAEMIA 28 0.0006
830 TACHYPNOEA 8 0.0006
831 HEPATITIS 15 0.0006
832 PHOTOPHOBIA 11 0.0006
833 HEPATOTOXICITY 13 0.0006
834 INFLUENZA LIKE ILLNESS 48 0.0006
835 WHITE BLOOD CELL COUNT DECREASED 63 0.0006
836 DELUSION 9 0.0006
837 TOOTH LOSS 12 0.0006
838 NEUROTOXICITY 10 0.0006
839 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
840 SHOCK 13 0.0006
841 BLOOD GLUCOSE DECREASED 27 0.0006
842 GALLBLADDER DISORDER 10 0.0006
843 INTERSTITIAL LUNG DISEASE 27 0.0006
844 SINUS DISORDER 11 0.0006
845 GASTROENTERITIS VIRAL 10 0.0006
846 HYPERTHYROIDISM 8 0.0006
847 HYPOKINESIA 8 0.0006
848 DYSPHONIA 32 0.0005
849 SKIN LESION 15 0.0005
850 FLATULENCE 31 0.0005
851 ERYTHEMA 112 0.0005
852 WEIGHT INCREASED 122 0.0005
853 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 14 0.0005
854 URTICARIA 91 0.0005
855 BONE MARROW FAILURE 11 0.0005
856 THINKING ABNORMAL 10 0.0005
857 IRRITABILITY 32 0.0005
858 HYPOAESTHESIA ORAL 8 0.0005
859 ABNORMAL BEHAVIOUR 21 0.0005
860 LACRIMATION INCREASED 16 0.0005
861 NEUTROPENIA 72 0.0005
862 UNEVALUABLE EVENT 40 0.0005
863 SEPTIC SHOCK 23 0.0005
864 HAEMORRHAGE 55 0.0005
865 PLATELET COUNT DECREASED 56 0.0005
866 DISCOMFORT 32 0.0005
867 THROAT TIGHTNESS 14 0.0005
868 NEUROPATHY PERIPHERAL 49 0.0005
869 NERVOUS SYSTEM DISORDER 16 0.0005
870 CHOKING 10 0.0005
871 SKIN CANCER 11 0.0005
872 CYANOSIS 8 0.0005
873 PNEUMOTHORAX 8 0.0005
874 HYPOTHYROIDISM 16 0.0005
875 BURNING SENSATION 35 0.0005
876 MOVEMENT DISORDER 16 0.0005
877 TOOTHACHE 9 0.0005
878 RHEUMATOID ARTHRITIS 56 0.0005
879 PSORIATIC ARTHROPATHY 20 0.0005
880 ENCEPHALOPATHY 12 0.0005
881 PHOTOSENSITIVITY REACTION 8 0.0005
882 SWELLING 45 0.0005
883 SUICIDAL IDEATION 44 0.0005
884 LEUKOPENIA 24 0.0005
885 SKIN DISORDER 16 0.0005
886 DRUG INTOLERANCE 46 0.0005
887 MUSCULOSKELETAL DISORDER 9 0.0005
888 CARDIOVASCULAR DISORDER 12 0.0005
889 DRUG PRESCRIBING ERROR 9 0.0005
890 HYPOACUSIS 20 0.0005
891 TREATMENT NONCOMPLIANCE 25 0.0005
892 LOCALISED INFECTION 11 0.0005
893 EMOTIONAL DISORDER 14 0.0005
894 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
895 DRUG ERUPTION 8 0.0005
896 ASTHMA 51 0.0005
897 SKIN EXFOLIATION 38 0.0004
898 FUNGAL INFECTION 15 0.0004
899 GAIT INABILITY 15 0.0004
900 INFLUENZA 50 0.0004
901 ILL-DEFINED DISORDER 27 0.0004
902 NEUTROPHIL COUNT DECREASED 18 0.0004
903 PNEUMONIA ASPIRATION 11 0.0004
904 CARDIAC DISORDER 41 0.0004
905 LUNG NEOPLASM MALIGNANT 18 0.0004
906 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
907 OSTEONECROSIS 14 0.0004
908 INTESTINAL OBSTRUCTION 16 0.0004
909 GASTROINTESTINAL DISORDER 38 0.0004
910 RESPIRATORY TRACT INFECTION 11 0.0004
911 HERPES ZOSTER 24 0.0004
912 OVERDOSE 90 0.0004
913 FIBROMYALGIA 10 0.0004
914 ORAL HERPES 8 0.0004
915 ASCITES 12 0.0004
916 PSYCHOTIC DISORDER 12 0.0004
917 UPPER LIMB FRACTURE 8 0.0004
918 PRODUCT SUBSTITUTION ISSUE 23 0.0004
919 ARTHROPATHY 22 0.0004
920 DRUG INEFFECTIVE 516 0.0004
921 ANAPHYLACTIC SHOCK 10 0.0004
922 COMPLETED SUICIDE 32 0.0004
923 KNEE ARTHROPLASTY 8 0.0004
924 SUICIDE ATTEMPT 23 0.0004
925 FEBRILE NEUTROPENIA 25 0.0004
926 NASOPHARYNGITIS 69 0.0004
927 INFECTION 54 0.0004
928 EMOTIONAL DISTRESS 44 0.0004
929 APPLICATION SITE PAIN 8 0.0004
930 LIVER DISORDER 16 0.0004
931 PSORIASIS 47 0.0004
932 PLASMA CELL MYELOMA 14 0.0004
933 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
934 SINUSITIS 36 0.0004
935 NEPHROLITHIASIS 16 0.0003
936 EYE IRRITATION 20 0.0003
937 SKIN BURNING SENSATION 24 0.0003
938 MYELOSUPPRESSION 12 0.0003
939 DRUG EFFECT INCOMPLETE 12 0.0003
940 CONTRAINDICATED PRODUCT ADMINISTERED 10 0.0003
941 MOOD ALTERED 9 0.0003
942 DRUG ADMINISTRATION ERROR 10 0.0003
943 THROMBOSIS 26 0.0003
944 DISEASE RECURRENCE 15 0.0003
945 PANCREATIC CARCINOMA 9 0.0003
946 MUCOSAL INFLAMMATION 8 0.0003
947 WRONG TECHNIQUE IN DRUG USAGE PROCESS 11 0.0003
948 MALIGNANT NEOPLASM PROGRESSION 31 0.0003
949 DISEASE PROGRESSION 35 0.0003
950 GASTRIC DISORDER 10 0.0003
951 THERAPY NON-RESPONDER 13 0.0003
952 PRODUCT USE ISSUE 52 0.0003
953 INFUSION RELATED REACTION 18 0.0003
954 LABORATORY TEST ABNORMAL 8 0.0003
955 INJECTION SITE MASS 10 0.0003
956 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
957 BONE DENSITY DECREASED 8 0.0003
958 DRUG DOSE OMISSION 42 0.0003
959 PRODUCT ADHESION ISSUE 9 0.0003
960 DRUG WITHDRAWAL SYNDROME 22 0.0003
961 PRODUCT QUALITY ISSUE 34 0.0003
962 DRUG EFFECT DECREASED 13 0.0002
963 NEOPLASM MALIGNANT 16 0.0002
964 ROAD TRAFFIC ACCIDENT 10 0.0002
965 SURGERY 13 0.0002
966 THERAPY INTERRUPTED 15 0.0002
967 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
968 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
969 SKIN IRRITATION 9 0.0002
970 THERAPY CESSATION 10 0.0002
971 TREATMENT FAILURE 16 0.0002
972 DEATH 166 0.0002
973 INCORRECT DOSE ADMINISTERED 43 0.0002
974 THERAPEUTIC RESPONSE DECREASED 11 0.0002
975 ILLNESS 18 0.0002
976 PRODUCT DOSE OMISSION 11 0.0002
977 UNDERDOSE 12 0.0002
978 DRUG DEPENDENCE 26 0.0002
979 PROSTATE CANCER 13 0.0002
980 BLADDER CANCER 9 0.0002
981 INJECTION SITE PRURITUS 10 0.0001
982 INJECTION SITE REACTION 10 0.0001
983 INJECTION SITE PAIN 43 0.0001
984 BREAST CANCER 13 0.0001
985 INJECTION SITE HAEMORRHAGE 11 0.0001
986 INJECTION SITE SWELLING 10 0.0001
987 DEVICE MALFUNCTION 9 0.0001
988 ADVERSE EVENT 11 0.0001
989 INJECTION SITE ERYTHEMA 14 0.0001
990 HOSPITALISATION 17 0.0001
991 ACNE 8 0.0001
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
993 PRODUCT DOSE OMISSION ISSUE 26 0.0001